Drawing for PROVEPEP

USPTO serial 86464594

PROVEPEP

Reviewed by CopyMark Law Group

Reg. 4854108Status 710
Filing date
Status date
Registration date
Nov 17, 2015
Examiner
POLLACK, ALISON FRIEDBERG
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PROVEPEP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron Y. Silverstein

AARON Y. SILVERSTEIN SAUNDERS & SILVERSTEIN LLP14 CEDAR ST STE 224AMESBURY, MA 01913-1831UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science; Protein, namely, protein arrays for medical research, protein in raw material form for medical research; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for medical laboratory useSECTION 8 - CANCELLED—
005Proteins for medical and pharmaceutical use, namely, protein arrays for medical diagnosis purposes, bone morphogenetic protein for use as a bone growth media, interferon-alpha-2a and interferon-alpha-2b medication used in treatment of viral diseases, hepatitis B and C, and used in treatment of cancers and granulocyte-colony stimulating factor medication for the treatment of neutropenia; Peptides for medical and pharmaceutical use, namely, synthetic peptides for the treatment of diabetes, synthetic peptides derived from venom for treating pain, and synthetic peptides used in the treatment of cancerSECTION 8 - CANCELLED—
042Research and design in the field of chemicals; Research and design in the field of peptides and proteins; Industrial analysis and research services in the field of chemicals; Industrial analysis and research services in the field of peptides and proteins; Pharmaceutical research and development; medical research; Medical and pharmaceutical research and development in the field of peptides and proteinsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 27, 2022C8..CANCELLED SEC. 8 (6-YR)—
Nov 17, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 13, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jan 24, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 17, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 1, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 1, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 12, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 29, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 27, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 27, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Jul 27, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 27, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 27, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 13, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 13, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 6, 2015ALIEASSIGNED TO LIE—
Jun 26, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 16, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2015DOCKASSIGNED TO EXAMINER—
Dec 3, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 28, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance